Division of Vascular Surgery, Saiseikai Central Hospital, Minato, Tokyo, Japan.
Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
J Vasc Surg. 2018 Oct;68(4):998-1006.e2. doi: 10.1016/j.jvs.2018.01.048.
The objective of this study was to validate the usefulness of retroperitoneal hematoma volume as a predictor of perioperative mortality after endovascular aneurysm repair (EVAR) for ruptured abdominal aortic aneurysm (rAAA).
We retrospectively reviewed consecutive patients with rAAA who underwent the unified EVAR first protocol between 2012 and 2016 at any one of three participating institutions in Japan and were prospectively registered in a dedicated database. Only patients with preoperative computed tomography scans adequate for three-dimensional volumetric analysis were included. Volumetry was used to measure the retroperitoneal hematoma volume. To adjust for body size differences between patients, the retroperitoneal hematoma volume was divided by the abdominal cavity volume, and the predictive power of this ratio was validated using appropriate statistical methods.
Of 114 patients with rAAA managed during the study period, 101 (88.6%) underwent EVAR, 9 (7.9%) underwent open surgical repair, and 4 (3.5%) did not undergo any repair. Finally, 82 of 101 patients treated with EVAR were included in the analysis. Within 30 days after EVAR, the mortality rates for the 82 patients included in the analysis and the 19 excluded patients were 24.4% and 31.6%, respectively, without statistically significant differences (P = .518). The retroperitoneal hematoma volume ratio was 3.59% ± 2.46% and 7.63% ± 3.45% in survivors and nonsurvivors, respectively (P < .001). Univariate analysis of other preoperative demographic and anatomic factors revealed that a Glasgow Aneurysm Score >85, systolic blood pressure <90 mm Hg, loss of consciousness, and mean minimum right external iliac artery diameter were statistically significant. Receiver operating characteristic curve analysis for the prediction of perioperative mortality revealed that retroperitoneal hematoma volume ratio was the best predictor of perioperative mortality in patients with rAAA of type >III in the Fitzgerald classification (area under the curve: retroperitoneal hematoma volume ratio, 0.880; Glasgow Aneurysm Score, 0.587; P < .001). Based on the Youden index, the optimal cutoff for the retroperitoneal hematoma volume ratio was 6.97%, providing a sensitivity of 0.833 and specificity of 0.860.
Our study suggests that retroperitoneal hematoma volume may be a good predictor of perioperative mortality after EVAR for rAAA, especially for patients with Fitzgerald classification >III and a best cutoff value of 6.97%.
本研究旨在验证腹膜后血肿体积作为预测破裂腹主动脉瘤(rAAA)血管内修复(EVAR)术后围手术期死亡率的指标的有效性。
我们回顾性分析了 2012 年至 2016 年期间在日本三家参与机构之一采用统一 EVAR 第一方案治疗的 rAAA 连续患者,并前瞻性地在专用数据库中进行了登记。仅纳入术前 CT 扫描足以进行三维容积分析的患者。使用容积法测量腹膜后血肿体积。为了调整患者之间的体型差异,将腹膜后血肿体积除以腹腔体积,并使用适当的统计方法验证该比值的预测能力。
在研究期间,114 例 rAAA 患者中,101 例(88.6%)接受了 EVAR 治疗,9 例(7.9%)接受了开放手术修复,4 例(3.5%)未进行任何修复。最终,101 例接受 EVAR 治疗的患者中有 82 例被纳入分析。在 EVAR 后 30 天内,纳入分析的 82 例患者和未纳入分析的 19 例患者的死亡率分别为 24.4%和 31.6%,差异无统计学意义(P =.518)。幸存者和非幸存者的腹膜后血肿体积比分别为 3.59%±2.46%和 7.63%±3.45%(P<.001)。对其他术前人口统计学和解剖因素的单因素分析显示,格拉斯哥动脉瘤评分>85、收缩压<90mmHg、意识丧失和右髂外动脉最小平均直径是有统计学意义的。预测围手术期死亡率的受试者工作特征曲线分析显示,腹膜后血肿体积比是法兹特分类中>III 型 rAAA 患者围手术期死亡率的最佳预测指标(曲线下面积:腹膜后血肿体积比,0.880;格拉斯哥动脉瘤评分,0.587;P<.001)。根据约登指数,腹膜后血肿体积比的最佳截断值为 6.97%,其敏感性为 0.833,特异性为 0.860。
本研究表明,腹膜后血肿体积可能是预测 rAAA 患者 EVAR 术后围手术期死亡率的一个很好的指标,尤其是对于法兹特分类>III 型患者,最佳截断值为 6.97%。